Information  X 
Enter a valid email address

Company Name matching 'Orion Oyj'

Date
Time Source
Company
Announcement
16 Apr 2019 7:00 am GNW     Orion Oyj 297,000 Orion Corporation A shares converted into B shares
11 Apr 2019 8:30 am GNW     Orion Oyj Publishing of Orion Corporation's Interim Report for January-March 2019 on 25 April 2019
27 Mar 2019 1:16 pm GNW     Orion Oyj Invitation to Orion's Capital Markets Day in Helsinki on Wednesday 22 May 2019
26 Mar 2019 3:30 pm GNW     Orion Oyj Orion Corporation: Organising meeting of the Board of Directors
  2:45 pm GNW     Orion Oyj Orion Corporation: Decisions by the AGM on 26 March 2019
08 Mar 2019 6:30 am GNW     Orion Oyj Darolutamide submitted for European marketing authorization
05 Mar 2019 6:00 am GNW     Orion Oyj Darolutamide submitted for marketing authorization in Japan
04 Mar 2019 10:00 am GNW     Orion Oyj Orion Group Financial Statement documents 2018 and Corporate Governance Statement published
01 Mar 2019 5:10 pm GNW     Orion Oyj Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019
27 Feb 2019 5:00 am GNW     Orion Oyj The rolling submission to FDA for darolutamide in the U.S. completed
14 Feb 2019 9:45 pm GNW     Orion Oyj Orion's and Bayer's darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial
11 Feb 2019 2:00 pm GNW     Orion Oyj Orion and Propeller Health partner to bring new digital medicines to people with asthma and COPD
06 Feb 2019 10:45 am GNW     Orion Oyj The Board of Directors of Orion Corporation decided on an incentive plan for key persons
  10:30 am GNW     Orion Oyj Notice to the Annual General Meeting of Orion Corporation
  10:00 am GNW     Orion Oyj Orion Group Financial Statement Release for 2018
05 Feb 2019 1:00 pm GNW     Orion Oyj Orion and Bayer jointly present new data in prostate cancer from the Darolutamide ARAMIS -study
04 Feb 2019 8:00 am GNW     Orion Oyj Orion intents to start an open label extension study to the REFALS phase 3 trial studying the effect of oral levosimendan in patients with ALS
23 Jan 2019 11:30 am GNW     Orion Oyj Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019
09 Jan 2019 10:40 am GNW     Orion Oyj Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation
04 Jan 2019 7:00 am GNW     Orion Oyj Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients
04 Dec 2018 1:00 pm GNW     Orion Oyj Orion acquires sales and distribution rights for certain European Countries for Parkinson's disease drug Stalevo
01 Nov 2018 7:30 am GNW     Orion Oyj Orion Research Foundation grants million euros for research in 2019
30 Oct 2018 4:30 pm GNW     Orion Oyj Composition of the Nomination Committee of Orion Corporation
24 Oct 2018 10:30 am GNW     Orion Oyj Orion and Amgen to collaborate on the commercialisation of AMGEVITA® (biosimilar adalimumab) in Finland
  10:00 am GNW     Orion Oyj Orion Group Interim Report January-September 2018
  6:30 am GNW     Orion Oyj Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer - The primary endpoint was met
10 Oct 2018 11:00 am GNW     Orion Oyj Publishing of Orion Corporation's Interim Report for January-September 2018 on 24 October 2018
19 Sep 2018 9:45 am GNW     Orion Oyj Changes in responsibility areas of the Orion Group Executive Management Board
17 Sep 2018 10:00 am GNW     Orion Oyj Creation of novel medicines and better patient care for the future in an ecosystem
10 Sep 2018 8:00 am GNW     Orion Oyj Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation
18 Jul 2018 10:00 am GNW     Orion Oyj Orion Group Half-Year Financial Report January-June 2018
  9:00 am GNW     Orion Oyj Orion Corporation's financial reporting and Annual General Meeting in 2019
06 Jul 2018 9:00 am GNW     Orion Oyj Orion has started a Phase III trial to develop a drug for ALS - The patient recruitment has begun
05 Jul 2018 9:30 am GNW     Orion Oyj Publishing of Orion Corporation's Half-Year Financial Report for January-June 2018 on 18 July 2018
14 Jun 2018 7:00 am GNW     Orion Oyj Fermion's new plant operational in Hanko - nearly 100% of production is exported
13 Jun 2018 7:00 am GNW     Orion Oyj Orion to join John Nurminen Foundation's Clean Baltic Sea projects as a new main partner
30 Apr 2018 10:15 am GNW     Orion Oyj Orion has completed the sale of Orion Diagnostica business division
24 Apr 2018 10:00 am GNW     Orion Oyj Orion Group Interim Report January-March 2018
20 Apr 2018 11:30 pm GNW     Orion Oyj Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook
10 Apr 2018 10:00 am GNW     Orion Oyj Publishing of Orion Corporation's Interim Report for January-March 2018 on 24 April 2018
03 Apr 2018 8:30 am GNW     Orion Oyj Status update of the Phase III ARAMIS clinical trial with darolutamide in patients with non-metastatic castration-resistant prostate cancer
20 Mar 2018 3:30 pm GNW     Orion Oyj Orion Corporation: Organising meeting of the Board of Directors
  2:15 pm GNW     Orion Oyj Orion Corporation: Decisions by the AGM on 20 March 2018
19 Mar 2018 10:30 am GNW     Orion Oyj Orion has received positive conclusions for the salmeterol-fluticasone Easyhaler® combination under the EU's decentralized procedures
01 Mar 2018 5:10 pm GNW     Orion Oyj Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018
28 Feb 2018 8:45 am GNW     Orion Oyj Orion's statutory co-operation negotiations completed
26 Feb 2018 11:00 am GNW     Orion Oyj Orion Group Financial Statement documents 2017 and Corporate Governance Statement published
07 Feb 2018 11:00 am GNW     Orion Oyj Notice to the annual general meeting of Orion Corporation
  10:45 am GNW     Orion Oyj Orion Group Financial Statement Release for 2017
24 Jan 2018 3:25 pm GNW     Orion Oyj Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2018 AGM of Orion Corporation
  9:45 am GNW     Orion Oyj Publishing of Orion Corporation's Financial Statement Release for 2017 on 7 February 2018
23 Jan 2018 10:20 am GNW     Orion Oyj Orion to investigate possible sale of Orion Diagnostica
04 Jan 2018 9:15 am GNW     Orion Oyj Orion to renew operating model of its laboratories
07 Nov 2017 6:30 am GNW     Orion Oyj Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation
26 Oct 2017 4:45 pm GNW     Orion Oyj Composition of the Nomination Committee of Orion Corporation
  10:00 am GNW     Orion Oyj Orion Group Interim Report January-September 2017
12 Oct 2017 8:30 am GNW     Orion Oyj Publishing of Orion Corporation's Interim Report for January-September 2017 on 26 October 2017
05 Oct 2017 10:35 am GNW     Orion Oyj Orion receives Lean Prize 2016
22 Sep 2017 6:30 am GNW     Orion Oyj Orion Pharma scientists led research group wins award for study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs
01 Aug 2017 7:00 am GNW     Orion Oyj 146,000 Orion Corporation A shares converted into B shares


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t